<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2020-08-12" version="183">
<accession>Q14432</accession>
<accession>O60865</accession>
<accession>Q13348</accession>
<accession>Q17RD1</accession>
<name>PDE3A_HUMAN</name>
<protein>
<recommendedName>
<fullName>cGMP-inhibited 3',5'-cyclic phosphodiesterase A</fullName>
<ecNumber>3.1.4.17</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cyclic GMP-inhibited phosphodiesterase A</fullName>
<shortName>CGI-PDE A</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PDE3A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="3721" last="3725">
<title>Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase.</title>
<authorList>
<person name="Meacci E."/>
<person name="Taira M."/>
<person name="Moos M. Jr."/>
<person name="Smith C.J."/>
<person name="Movsesian M.A."/>
<person name="Degerman E."/>
<person name="Belfrage P."/>
<person name="Manganiello V."/>
</authorList>
<dbReference type="PubMed" id="1315035"/>
<dbReference type="DOI" id="10.1073/pnas.89.9.3721"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Myocardium</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2003-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Liu H."/>
<person name="Manganiello V."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 12; 63-64 AND 354-371</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Blood" volume="88" first="1321" last="1329">
<title>Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis.</title>
<authorList>
<person name="Cheung P.P."/>
<person name="Xu H."/>
<person name="McLaughlin M.M."/>
<person name="Ghazaleh F.A."/>
<person name="Livi G.P."/>
<person name="Colman R.W."/>
</authorList>
<dbReference type="PubMed" id="8695850"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ASN-12</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Chem. Biol. Interact." volume="119" first="593" last="598">
<title>Molecular biological characterization of phosphodiesterase 3A from human corpus cavernosum.</title>
<authorList>
<person name="Kuthe A."/>
<person name="Eckel H."/>
<person name="Stief C.G."/>
<person name="Uckert S."/>
<person name="Forssmann W.-G."/>
<person name="Jonas U."/>
<person name="Maegert H.-J."/>
</authorList>
<dbReference type="PubMed" id="10421499"/>
<dbReference type="DOI" id="10.1016/s0009-2797(99)00074-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Penis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="Biochim. Biophys. Acta" volume="1205" first="189" last="198">
<title>Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase.</title>
<authorList>
<person name="Degerman E."/>
<person name="Moos M. Jr."/>
<person name="Rascon A."/>
<person name="Vasta V."/>
<person name="Meacci E."/>
<person name="Smith C.J."/>
<person name="Lindgren S."/>
<person name="Andersson K.-E."/>
<person name="Belfrage P."/>
<person name="Manganiello V."/>
</authorList>
<dbReference type="PubMed" id="8155697"/>
<dbReference type="DOI" id="10.1016/0167-4838(94)90233-x"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-520</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-492 AND SER-520</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2015" name="Nat. Genet." volume="47" first="647" last="653">
<title>PDE3A mutations cause autosomal dominant hypertension with brachydactyly.</title>
<authorList>
<person name="Maass P.G."/>
<person name="Aydin A."/>
<person name="Luft F.C."/>
<person name="Schaechterle C."/>
<person name="Weise A."/>
<person name="Stricker S."/>
<person name="Lindschau C."/>
<person name="Vaegler M."/>
<person name="Qadri F."/>
<person name="Toka H.R."/>
<person name="Schulz H."/>
<person name="Krawitz P.M."/>
<person name="Parkhomchuk D."/>
<person name="Hecht J."/>
<person name="Hollfinger I."/>
<person name="Wefeld-Neuenfeld Y."/>
<person name="Bartels-Klein E."/>
<person name="Muehl A."/>
<person name="Kann M."/>
<person name="Schuster H."/>
<person name="Chitayat D."/>
<person name="Bialer M.G."/>
<person name="Wienker T.F."/>
<person name="Ott J."/>
<person name="Rittscher K."/>
<person name="Liehr T."/>
<person name="Jordan J."/>
<person name="Plessis G."/>
<person name="Tank J."/>
<person name="Mai K."/>
<person name="Naraghi R."/>
<person name="Hodge R."/>
<person name="Hopp M."/>
<person name="Hattenbach L.O."/>
<person name="Busjahn A."/>
<person name="Rauch A."/>
<person name="Vandeput F."/>
<person name="Gong M."/>
<person name="Rueschendorf F."/>
<person name="Huebner N."/>
<person name="Haller H."/>
<person name="Mundlos S."/>
<person name="Bilginturan N."/>
<person name="Movsesian M.A."/>
<person name="Klussmann E."/>
<person name="Toka O."/>
<person name="Baehring S."/>
</authorList>
<dbReference type="PubMed" id="25961942"/>
<dbReference type="DOI" id="10.1038/ng.3302"/>
</citation>
<scope>INVOLVEMENT IN HTNB</scope>
<scope>VARIANTS HTNB ALA-445; ASN-445; SER-445; THR-447; VAL-447 AND VAL-449</scope>
<scope>CHARACTERIZATION OF VARIANTS HTNB ALA-445; ASN-445; SER-445; THR-447; VAL-447 AND VAL-449</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1120</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="6">Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>a nucleoside 3',5'-cyclic phosphate + H2O = a nucleoside 5'-phosphate + H(+)</text>
<dbReference type="Rhea" id="RHEA:14653"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57867"/>
<dbReference type="ChEBI" id="CHEBI:58464"/>
<dbReference type="EC" id="3.1.4.17"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="5">
<name>a divalent metal cation</name>
<dbReference type="ChEBI" id="CHEBI:60240"/>
</cofactor>
<text evidence="5">Binds 2 divalent metal cations per subunit. Site 1 may preferentially bind zinc ions, while site 2 has a preference for magnesium and/or manganese ions.</text>
</comment>
<comment type="activity regulation">
<text>Inhibited by cGMP.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7192066">
<id>Q14432</id>
</interactant>
<interactant intactId="EBI-1044254">
<id>Q9Y6D6</id>
<label>ARFGEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7192066">
<id>Q14432</id>
</interactant>
<interactant intactId="EBI-2837511">
<id>Q9Y6D5</id>
<label>ARFGEF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11">Membrane</location>
<topology evidence="11">Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="disease" evidence="9">
<disease id="DI-04464">
<name>Hypertension and brachydactyly syndrome</name>
<acronym>HTNB</acronym>
<description>A syndrome characterized by brachydactyly type E, severe salt-independent but age-dependent hypertension, an increased fibroblast growth rate, neurovascular contact at the rostral-ventrolateral medulla, and altered baroreflex blood pressure regulation. It results in death from stroke before age 50 years when untreated. Brachydactyly type E is characterized by shortening of the fingers mainly in the metacarpals and metatarsals.</description>
<dbReference type="MIM" id="112410"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the cyclic nucleotide phosphodiesterase family. PDE3 subfamily.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/PDE3"/>
<text>PDE3 entry</text>
</comment>
<dbReference type="EC" id="3.1.4.17"/>
<dbReference type="EMBL" id="M91667">
<property type="protein sequence ID" value="AAA35912.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U36798">
<property type="protein sequence ID" value="AAB18673.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ005036">
<property type="protein sequence ID" value="CAA06304.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC117369">
<property type="protein sequence ID" value="AAI17370.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC117371">
<property type="protein sequence ID" value="AAI17372.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31754.1"/>
<dbReference type="PIR" id="A44093">
<property type="entry name" value="A44093"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000912.3">
<property type="nucleotide sequence ID" value="NM_000921.4"/>
</dbReference>
<dbReference type="PDB" id="1LRC">
<property type="method" value="Model"/>
<property type="chains" value="A=812-1017"/>
</dbReference>
<dbReference type="PDBsum" id="1LRC"/>
<dbReference type="SMR" id="Q14432"/>
<dbReference type="BioGRID" id="111165">
<property type="interactions" value="31"/>
</dbReference>
<dbReference type="DIP" id="DIP-42197N"/>
<dbReference type="IntAct" id="Q14432">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="MINT" id="Q14432"/>
<dbReference type="STRING" id="9606.ENSP00000351957"/>
<dbReference type="BindingDB" id="Q14432"/>
<dbReference type="ChEMBL" id="CHEMBL241"/>
<dbReference type="DrugBank" id="DB01223">
<property type="generic name" value="Aminophylline"/>
</dbReference>
<dbReference type="DrugBank" id="DB01427">
<property type="generic name" value="Amrinone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00261">
<property type="generic name" value="Anagrelide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00201">
<property type="generic name" value="Caffeine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01166">
<property type="generic name" value="Cilostazol"/>
</dbReference>
<dbReference type="DrugBank" id="DB04880">
<property type="generic name" value="Enoximone"/>
</dbReference>
<dbReference type="DrugBank" id="DB05266">
<property type="generic name" value="Ibudilast"/>
</dbReference>
<dbReference type="DrugBank" id="DB00922">
<property type="generic name" value="Levosimendan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00235">
<property type="generic name" value="Milrinone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01303">
<property type="generic name" value="Oxtriphylline"/>
</dbReference>
<dbReference type="DrugBank" id="DB00277">
<property type="generic name" value="Theophylline"/>
</dbReference>
<dbReference type="DrugBank" id="DB08811">
<property type="generic name" value="Tofisopam"/>
</dbReference>
<dbReference type="DrugBank" id="DB09283">
<property type="generic name" value="Trapidil"/>
</dbReference>
<dbReference type="DrugCentral" id="Q14432"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1298"/>
<dbReference type="iPTMnet" id="Q14432"/>
<dbReference type="PhosphoSitePlus" id="Q14432"/>
<dbReference type="BioMuta" id="PDE3A"/>
<dbReference type="DMDM" id="47117888"/>
<dbReference type="EPD" id="Q14432"/>
<dbReference type="jPOST" id="Q14432"/>
<dbReference type="MassIVE" id="Q14432"/>
<dbReference type="MaxQB" id="Q14432"/>
<dbReference type="PaxDb" id="Q14432"/>
<dbReference type="PeptideAtlas" id="Q14432"/>
<dbReference type="PRIDE" id="Q14432"/>
<dbReference type="ProteomicsDB" id="59987"/>
<dbReference type="Antibodypedia" id="2869">
<property type="antibodies" value="217 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359062">
<property type="protein sequence ID" value="ENSP00000351957"/>
<property type="gene ID" value="ENSG00000172572"/>
</dbReference>
<dbReference type="GeneID" id="5139"/>
<dbReference type="KEGG" id="hsa:5139"/>
<dbReference type="UCSC" id="uc001reh.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5139"/>
<dbReference type="DisGeNET" id="5139"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000172572.6"/>
<dbReference type="GeneCards" id="PDE3A"/>
<dbReference type="HGNC" id="HGNC:8778">
<property type="gene designation" value="PDE3A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000172572">
<property type="expression patterns" value="Tissue enhanced (heart)"/>
</dbReference>
<dbReference type="MalaCards" id="PDE3A"/>
<dbReference type="MIM" id="112410">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="123805">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14432"/>
<dbReference type="OpenTargets" id="ENSG00000172572"/>
<dbReference type="Orphanet" id="1276">
<property type="disease" value="Brachydactyly-arterial hypertension syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33126"/>
<dbReference type="eggNOG" id="ENOG502QSV8">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156628"/>
<dbReference type="HOGENOM" id="CLU_008844_0_0_1"/>
<dbReference type="KO" id="K19021"/>
<dbReference type="OMA" id="GCWGDLV"/>
<dbReference type="OrthoDB" id="1051097at2759"/>
<dbReference type="PhylomeDB" id="Q14432"/>
<dbReference type="TreeFam" id="TF329631"/>
<dbReference type="BRENDA" id="3.1.4.17">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q14432"/>
<dbReference type="Reactome" id="R-HSA-418555">
<property type="pathway name" value="G alpha (s) signalling events"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q14432"/>
<dbReference type="SIGNOR" id="Q14432"/>
<dbReference type="BioGRID-ORCS" id="5139">
<property type="hits" value="6 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PDE3A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="5139"/>
<dbReference type="Pharos" id="Q14432">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14432"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q14432">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000172572">
<property type="expression patterns" value="Expressed in heart right ventricle and 182 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q14432">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004115">
<property type="term" value="F:3',5'-cyclic-AMP phosphodiesterase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004119">
<property type="term" value="F:cGMP-inhibited cyclic-nucleotide phosphodiesterase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019933">
<property type="term" value="P:cAMP-mediated signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071321">
<property type="term" value="P:cellular response to cGMP"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071560">
<property type="term" value="P:cellular response to transforming growth factor beta stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019934">
<property type="term" value="P:cGMP-mediated signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006629">
<property type="term" value="P:lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043951">
<property type="term" value="P:negative regulation of cAMP-mediated signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043116">
<property type="term" value="P:negative regulation of vascular permeability"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001556">
<property type="term" value="P:oocyte maturation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060282">
<property type="term" value="P:positive regulation of oocyte development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043117">
<property type="term" value="P:positive regulation of vascular permeability"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040020">
<property type="term" value="P:regulation of meiotic nuclear division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00077">
<property type="entry name" value="HDc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.1300.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003607">
<property type="entry name" value="HD/PDEase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002073">
<property type="entry name" value="PDEase_catalytic_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036971">
<property type="entry name" value="PDEase_catalytic_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR023174">
<property type="entry name" value="PDEase_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00233">
<property type="entry name" value="PDEase_I"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00471">
<property type="entry name" value="HDc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00126">
<property type="entry name" value="PDEASE_I_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51845">
<property type="entry name" value="PDEASE_I_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0114">cAMP</keyword>
<keyword id="KW-0140">cGMP</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="cGMP-inhibited 3',5'-cyclic phosphodiesterase A" id="PRO_0000198799">
<location>
<begin position="1"/>
<end position="1141"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="61"/>
<end position="81"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="130"/>
<end position="150"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="160"/>
<end position="180"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="185"/>
<end position="205"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="210"/>
<end position="230"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="232"/>
<end position="252"/>
</location>
</feature>
<feature type="domain" description="PDEase" evidence="8">
<location>
<begin position="674"/>
<end position="1093"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="95"/>
<end position="98"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="99"/>
<end position="102"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="288"/>
<end position="291"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Thr">
<location>
<begin position="440"/>
<end position="445"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="870"/>
<end position="873"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1040"/>
<end position="1045"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1121"/>
<end position="1125"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="5">
<location>
<position position="752"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Divalent metal cation 1" evidence="5">
<location>
<position position="756"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Divalent metal cation 1" evidence="5">
<location>
<position position="836"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Divalent metal cation 1" evidence="5">
<location>
<position position="837"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Divalent metal cation 2" evidence="5">
<location>
<position position="837"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Divalent metal cation 1" evidence="5">
<location>
<position position="950"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3">
<location>
<position position="312"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 3">
<location>
<position position="520"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="524"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="1033"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="1036"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="4">
<location>
<position position="1120"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12305038." id="VAR_059543" evidence="10">
<original>D</original>
<variation>N</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In HTNB; gain of function mutation with increased cAMP-hydrolytic activity; dbSNP:rs794726865." id="VAR_073869" evidence="9">
<original>T</original>
<variation>A</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In HTNB; gain of function mutation with increased cAMP-hydrolytic activity; dbSNP:rs794726864." id="VAR_073870" evidence="9">
<original>T</original>
<variation>N</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In HTNB; gain of function mutation with increased cAMP-hydrolytic activity; dbSNP:rs794726864." id="VAR_073871" evidence="9">
<original>T</original>
<variation>S</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In HTNB; gain of function mutation with increased cAMP-hydrolytic activity; dbSNP:rs794726866." id="VAR_073872" evidence="9">
<original>A</original>
<variation>T</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In HTNB; gain of function mutationwith increased cAMP-hydrolytic activity; dbSNP:rs794726867." id="VAR_073873" evidence="9">
<original>A</original>
<variation>V</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In HTNB; gain of function mutation with increased cAMP-hydrolytic activity; dbSNP:rs794726868." id="VAR_073874" evidence="9">
<original>G</original>
<variation>V</variation>
<location>
<position position="449"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB18673." ref="3" evidence="11">
<original>S</original>
<variation>C</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAB18673." ref="3" evidence="11">
<original>G</original>
<variation>A</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3 and 4; CAA06304." ref="3 4" evidence="11">
<original>HGLITDLLADPSLPPNVC</original>
<variation>TASLPTSWQTLLFHQTCA</variation>
<location>
<begin position="354"/>
<end position="371"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z0X4"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01192"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25961942"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8695850"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000305"/>
<sequence length="1141" mass="124979" checksum="E69504130F39EFEA" modified="2004-05-10" version="3">MAVPGDAARVRDKPVHSGVSQAPTAGRDCHHRADPASPRDSGCRGCWGDLVLQPLRSSRKLSSALCAGSLSFLLALLVRLVRGEVGCDLEQCKEAAAAEEEEAAPGAEGGVFPGPRGGAPGGGARLSPWLQPSALLFSLLCAFFWMGLYLLRAGVRLPLAVALLAACCGGEALVQIGLGVGEDHLLSLPAAGVVLSCLAAATWLVLRLRLGVLMIALTSAVRTVSLISLERFKVAWRPYLAYLAGVLGILLARYVEQILPQSAEAAPREHLGSQLIAGTKEDIPVFKRRRRSSSVVSAEMSGCSSKSHRRTSLPCIPREQLMGHSEWDHKRGPRGSQSSGTSITVDIAVMGEAHGLITDLLADPSLPPNVCTSLRAVSNLLSTQLTFQAIHKPRVNPVTSLSENYTCSDSEESSEKDKLAIPKRLRRSLPPGLLRRVSSTWTTTTSATGLPTLEPAPVRRDRSTSIKLQEAPSSSPDSWNNPVMMTLTKSRSFTSSYAISAANHVKAKKQSRPGALAKISPLSSPCSSPLQGTPASSLVSKISAVQFPESADTTAKQSLGSHRALTYTQSAPDLSPQILTPPVICSSCGRPYSQGNPADEPLERSGVATRTPSRTDDTAQVTSDYETNNNSDSSDIVQNEDETECLREPLRKASACSTYAPETMMFLDKPILAPEPLVMDNLDSIMEQLNTWNFPIFDLVENIGRKCGRILSQVSYRLFEDMGLFEAFKIPIREFMNYFHALEIGYRDIPYHNRIHATDVLHAVWYLTTQPIPGLSTVINDHGSTSDSDSDSGFTHGHMGYVFSKTYNVTDDKYGCLSGNIPALELMALYVAAAMHDYDHPGRTNAFLVATSAPQAVLYNDRSVLENHHAAAAWNLFMSRPEYNFLINLDHVEFKHFRFLVIEAILATDLKKHFDFVAKFNGKVNDDVGIDWTNENDRLLVCQMCIKLADINGPAKCKELHLQWTDGIVNEFYEQGDEEASLGLPISPFMDRSAPQLANLQESFISHIVGPLCNSYDSAGLMPGKWVEDSDESGDTDDPEEEEEEAPAPNEEETCENNESPKKKTFKRRKIYCQITQHLLQNHKMWKKVIEEEQRLAGIENQSLDQTPQSHSSEQIQAIKEEEEEKGKPRGEEIPTQKPDQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

